img

Global Autologous Cell Therapy Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Autologous Cell Therapy Products Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Autologous cell therapy is a medical treatment approach that involves using a patient's own cells to treat a specific medical condition or promote healing. This type of therapy is personalized and based on the principle that cells from the patient's own body are less likely to trigger immune responses or rejection, making it a potentially effective and safe treatment option for various conditions.
Autologous Cell Therapy Products report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Autologous Cell Therapy Products market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Cancer and Hemophilia are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Autologous Cell Therapy Products industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Autologous Cell Therapy Products key manufacturers include Novartis, Gilead Sciences, Bristol-Myers Squibb, Johnson & Johnson, Autolus Therapeutics, FOSUNKite, JW Therapeutics, CARsgen Therapeutics and Sorrento Therapeutics, etc. Novartis, Gilead Sciences, Bristol-Myers Squibb are top 3 players and held % sales share in total in 2022.
Autologous Cell Therapy Products can be divided into Autologous Stem Cell Transplants, Autologous T Cell Therapies, Platelet-Rich Plasma (PRP) Therapy and Others, etc. Autologous Stem Cell Transplants is the mainstream product in the market, accounting for % sales share globally in 2022.
Autologous Cell Therapy Products is widely used in various fields, such as Cancer, Hemophilia and Others,, etc. Cancer provides greatest supports to the Autologous Cell Therapy Products industry development. In 2022, global % sales of Autologous Cell Therapy Products went into Cancer filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Autologous Cell Therapy Products market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Gilead Sciences
Bristol-Myers Squibb
Johnson & Johnson
Autolus Therapeutics
FOSUNKite
JW Therapeutics
CARsgen Therapeutics
Sorrento Therapeutics
Mustang Bio
Cellectis
Allogene Therapeutics
Celyad Oncology
Bluebird Bio
Lonza
Segment by Type
Autologous Stem Cell Transplants
Autologous T Cell Therapies
Platelet-Rich Plasma (PRP) Therapy
Others

Segment by Application


Cancer
Hemophilia
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Autologous Cell Therapy Products market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Autologous Cell Therapy Products, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Autologous Cell Therapy Products industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Autologous Cell Therapy Products in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Autologous Cell Therapy Products introduction, etc. Autologous Cell Therapy Products Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Autologous Cell Therapy Products market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Autologous Cell Therapy Products Market Overview
1.1 Autologous Cell Therapy Products Product Overview
1.2 Autologous Cell Therapy Products Market Segment by Type
1.2.1 Autologous Stem Cell Transplants
1.2.2 Autologous T Cell Therapies
1.2.3 Platelet-Rich Plasma (PRP) Therapy
1.2.4 Others
1.3 Global Autologous Cell Therapy Products Market Size by Type
1.3.1 Global Autologous Cell Therapy Products Market Size Overview by Type (2018-2029)
1.3.2 Global Autologous Cell Therapy Products Historic Market Size Review by Type (2018-2024)
1.3.3 Global Autologous Cell Therapy Products Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Autologous Cell Therapy Products Sales Breakdown by Type (2018-2024)
1.4.2 Europe Autologous Cell Therapy Products Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Autologous Cell Therapy Products Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Autologous Cell Therapy Products Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Autologous Cell Therapy Products Sales Breakdown by Type (2018-2024)
2 Global Autologous Cell Therapy Products Market Competition by Company
2.1 Global Top Players by Autologous Cell Therapy Products Sales (2018-2024)
2.2 Global Top Players by Autologous Cell Therapy Products Revenue (2018-2024)
2.3 Global Top Players by Autologous Cell Therapy Products Price (2018-2024)
2.4 Global Top Manufacturers Autologous Cell Therapy Products Manufacturing Base Distribution, Sales Area, Product Type
2.5 Autologous Cell Therapy Products Market Competitive Situation and Trends
2.5.1 Autologous Cell Therapy Products Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Autologous Cell Therapy Products Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2022)
2.7 Date of Key Manufacturers Enter into Autologous Cell Therapy Products Market
2.8 Key Manufacturers Autologous Cell Therapy Products Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Autologous Cell Therapy Products Status and Outlook by Region
3.1 Global Autologous Cell Therapy Products Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Autologous Cell Therapy Products Historic Market Size by Region
3.2.1 Global Autologous Cell Therapy Products Sales in Volume by Region (2018-2024)
3.2.2 Global Autologous Cell Therapy Products Sales in Value by Region (2018-2024)
3.2.3 Global Autologous Cell Therapy Products Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Autologous Cell Therapy Products Forecasted Market Size by Region
3.3.1 Global Autologous Cell Therapy Products Sales in Volume by Region (2024-2029)
3.3.2 Global Autologous Cell Therapy Products Sales in Value by Region (2024-2029)
3.3.3 Global Autologous Cell Therapy Products Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Autologous Cell Therapy Products by Application
4.1 Autologous Cell Therapy Products Market Segment by Application
4.1.1 Cancer
4.1.2 Hemophilia
4.1.3 Others
4.2 Global Autologous Cell Therapy Products Market Size by Application
4.2.1 Global Autologous Cell Therapy Products Market Size Overview by Application (2018-2029)
4.2.2 Global Autologous Cell Therapy Products Historic Market Size Review by Application (2018-2024)
4.2.3 Global Autologous Cell Therapy Products Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Autologous Cell Therapy Products Sales Breakdown by Application (2018-2024)
4.3.2 Europe Autologous Cell Therapy Products Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Autologous Cell Therapy Products Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Autologous Cell Therapy Products Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Autologous Cell Therapy Products Sales Breakdown by Application (2018-2024)
5 North America Autologous Cell Therapy Products by Country
5.1 North America Autologous Cell Therapy Products Historic Market Size by Country
5.1.1 North America Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Autologous Cell Therapy Products Sales in Volume by Country (2018-2024)
5.1.3 North America Autologous Cell Therapy Products Sales in Value by Country (2018-2024)
5.2 North America Autologous Cell Therapy Products Forecasted Market Size by Country
5.2.1 North America Autologous Cell Therapy Products Sales in Volume by Country (2024-2029)
5.2.2 North America Autologous Cell Therapy Products Sales in Value by Country (2024-2029)
6 Europe Autologous Cell Therapy Products by Country
6.1 Europe Autologous Cell Therapy Products Historic Market Size by Country
6.1.1 Europe Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Autologous Cell Therapy Products Sales in Volume by Country (2018-2024)
6.1.3 Europe Autologous Cell Therapy Products Sales in Value by Country (2018-2024)
6.2 Europe Autologous Cell Therapy Products Forecasted Market Size by Country
6.2.1 Europe Autologous Cell Therapy Products Sales in Volume by Country (2024-2029)
6.2.2 Europe Autologous Cell Therapy Products Sales in Value by Country (2024-2029)
7 Asia-Pacific Autologous Cell Therapy Products by Region
7.1 Asia-Pacific Autologous Cell Therapy Products Historic Market Size by Region
7.1.1 Asia-Pacific Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Autologous Cell Therapy Products Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Autologous Cell Therapy Products Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Autologous Cell Therapy Products Forecasted Market Size by Region
7.2.1 Asia-Pacific Autologous Cell Therapy Products Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Autologous Cell Therapy Products Sales in Value by Region (2024-2029)
8 Latin America Autologous Cell Therapy Products by Country
8.1 Latin America Autologous Cell Therapy Products Historic Market Size by Country
8.1.1 Latin America Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Autologous Cell Therapy Products Sales in Volume by Country (2018-2024)
8.1.3 Latin America Autologous Cell Therapy Products Sales in Value by Country (2018-2024)
8.2 Latin America Autologous Cell Therapy Products Forecasted Market Size by Country
8.2.1 Latin America Autologous Cell Therapy Products Sales in Volume by Country (2024-2029)
8.2.2 Latin America Autologous Cell Therapy Products Sales in Value by Country (2024-2029)
9 Middle East and Africa Autologous Cell Therapy Products by Country
9.1 Middle East and Africa Autologous Cell Therapy Products Historic Market Size by Country
9.1.1 Middle East and Africa Autologous Cell Therapy Products Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Autologous Cell Therapy Products Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Autologous Cell Therapy Products Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Autologous Cell Therapy Products Forecasted Market Size by Country
9.2.1 Middle East and Africa Autologous Cell Therapy Products Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Autologous Cell Therapy Products Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Novartis
10.1.1 Novartis Company Information
10.1.2 Novartis Introduction and Business Overview
10.1.3 Novartis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Novartis Autologous Cell Therapy Products Products Offered
10.1.5 Novartis Recent Development
10.2 Gilead Sciences
10.2.1 Gilead Sciences Company Information
10.2.2 Gilead Sciences Introduction and Business Overview
10.2.3 Gilead Sciences Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Gilead Sciences Autologous Cell Therapy Products Products Offered
10.2.5 Gilead Sciences Recent Development
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Company Information
10.3.2 Bristol-Myers Squibb Introduction and Business Overview
10.3.3 Bristol-Myers Squibb Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bristol-Myers Squibb Autologous Cell Therapy Products Products Offered
10.3.5 Bristol-Myers Squibb Recent Development
10.4 Johnson & Johnson
10.4.1 Johnson & Johnson Company Information
10.4.2 Johnson & Johnson Introduction and Business Overview
10.4.3 Johnson & Johnson Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Johnson & Johnson Autologous Cell Therapy Products Products Offered
10.4.5 Johnson & Johnson Recent Development
10.5 Autolus Therapeutics
10.5.1 Autolus Therapeutics Company Information
10.5.2 Autolus Therapeutics Introduction and Business Overview
10.5.3 Autolus Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Autolus Therapeutics Autologous Cell Therapy Products Products Offered
10.5.5 Autolus Therapeutics Recent Development
10.6 FOSUNKite
10.6.1 FOSUNKite Company Information
10.6.2 FOSUNKite Introduction and Business Overview
10.6.3 FOSUNKite Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.6.4 FOSUNKite Autologous Cell Therapy Products Products Offered
10.6.5 FOSUNKite Recent Development
10.7 JW Therapeutics
10.7.1 JW Therapeutics Company Information
10.7.2 JW Therapeutics Introduction and Business Overview
10.7.3 JW Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.7.4 JW Therapeutics Autologous Cell Therapy Products Products Offered
10.7.5 JW Therapeutics Recent Development
10.8 CARsgen Therapeutics
10.8.1 CARsgen Therapeutics Company Information
10.8.2 CARsgen Therapeutics Introduction and Business Overview
10.8.3 CARsgen Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.8.4 CARsgen Therapeutics Autologous Cell Therapy Products Products Offered
10.8.5 CARsgen Therapeutics Recent Development
10.9 Sorrento Therapeutics
10.9.1 Sorrento Therapeutics Company Information
10.9.2 Sorrento Therapeutics Introduction and Business Overview
10.9.3 Sorrento Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Sorrento Therapeutics Autologous Cell Therapy Products Products Offered
10.9.5 Sorrento Therapeutics Recent Development
10.10 Mustang Bio
10.10.1 Mustang Bio Company Information
10.10.2 Mustang Bio Introduction and Business Overview
10.10.3 Mustang Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Mustang Bio Autologous Cell Therapy Products Products Offered
10.10.5 Mustang Bio Recent Development
10.11 Cellectis
10.11.1 Cellectis Company Information
10.11.2 Cellectis Introduction and Business Overview
10.11.3 Cellectis Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Cellectis Autologous Cell Therapy Products Products Offered
10.11.5 Cellectis Recent Development
10.12 Allogene Therapeutics
10.12.1 Allogene Therapeutics Company Information
10.12.2 Allogene Therapeutics Introduction and Business Overview
10.12.3 Allogene Therapeutics Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Allogene Therapeutics Autologous Cell Therapy Products Products Offered
10.12.5 Allogene Therapeutics Recent Development
10.13 Celyad Oncology
10.13.1 Celyad Oncology Company Information
10.13.2 Celyad Oncology Introduction and Business Overview
10.13.3 Celyad Oncology Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Celyad Oncology Autologous Cell Therapy Products Products Offered
10.13.5 Celyad Oncology Recent Development
10.14 Bluebird Bio
10.14.1 Bluebird Bio Company Information
10.14.2 Bluebird Bio Introduction and Business Overview
10.14.3 Bluebird Bio Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Bluebird Bio Autologous Cell Therapy Products Products Offered
10.14.5 Bluebird Bio Recent Development
10.15 Lonza
10.15.1 Lonza Company Information
10.15.2 Lonza Introduction and Business Overview
10.15.3 Lonza Autologous Cell Therapy Products Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Lonza Autologous Cell Therapy Products Products Offered
10.15.5 Lonza Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Autologous Cell Therapy Products Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Autologous Cell Therapy Products Industrial Chain Analysis
11.4 Autologous Cell Therapy Products Market Dynamics
11.4.1 Autologous Cell Therapy Products Industry Trends
11.4.2 Autologous Cell Therapy Products Market Drivers
11.4.3 Autologous Cell Therapy Products Market Challenges
11.4.4 Autologous Cell Therapy Products Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Autologous Cell Therapy Products Distributors
12.3 Autologous Cell Therapy Products Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Autologous Stem Cell Transplants
Table 2. Major Company of Autologous T Cell Therapies
Table 3. Major Company of Platelet-Rich Plasma (PRP) Therapy
Table 4. Major Company of Others
Table 5. Global Autologous Cell Therapy Products Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 7. Global Autologous Cell Therapy Products Sales Market Share in Volume by Type (2018-2024)
Table 8. Global Autologous Cell Therapy Products Sales by Type (2018-2024) & (US& Million)
Table 9. Global Autologous Cell Therapy Products Market Share in Value by Type (2018-2024)
Table 10. Global Autologous Cell Therapy Products Price by Type (2018-2024) & (US$/Unit)
Table 11. Global Autologous Cell Therapy Products Sales by Type (2024-2029) & (K Units)
Table 12. Global Autologous Cell Therapy Products Sales Market Share in Volume by Type (2024-2029)
Table 13. Global Autologous Cell Therapy Products Sales by Type (2024-2029) & (US$ Million)
Table 14. Global Autologous Cell Therapy Products Sales Market Share in Value by Type (2024-2029)
Table 15. Global Autologous Cell Therapy Products Price by Type (2024-2029) & (US$/Unit)
Table 16. North America Autologous Cell Therapy Products Sales by Type (2018-2024) & (K Units)
Table 17. North America Autologous Cell Therapy Products Sales by Type (2018-2024) & (US$ Million)
Table 18. Europe Autologous Cell Therapy Products Sales (K Units) by Type (2018-2024)
Table 19. Europe Autologous Cell Therapy Products Sales by Type (2018-2024) & (US$ Million)
Table 20. Asia-Pacific Autologous Cell Therapy Products Sales (K Units) by Type (2018-2024)
Table 21. Asia-Pacific Autologous Cell Therapy Products Sales by Type (2018-2024) & (US$ Million)
Table 22. Latin America Autologous Cell Therapy Products Sales (K Units) by Type (2018-2024)
Table 23. Latin America Autologous Cell Therapy Products Sales by Type (2018-2024) & (US$ Million)
Table 24. Middle East and Africa Autologous Cell Therapy Products Sales (K Units) by Type (2018-2024)
Table 25. Middle East and Africa Autologous Cell Therapy Products Sales by Type (2018-2024) & (US$ Million)
Table 26. Global Autologous Cell Therapy Products Sales by Company (2018-2024) & (K Units)
Table 27. Global Autologous Cell Therapy Products Sales Share by Company (2018-2024)
Table 28. Global Autologous Cell Therapy Products Revenue by Company (2018-2024) & (US$ Million)
Table 29. Global Autologous Cell Therapy Products Revenue Share by Company (2018-2024)
Table 30. Global Market Autologous Cell Therapy Products Price by Company (2018-2024) & (US$/Unit)
Table 31. Global Autologous Cell Therapy Products Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 32. Global Autologous Cell Therapy Products Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 33. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Autologous Cell Therapy Products as of 2022)
Table 34. Date of Key Manufacturers Enter into Autologous Cell Therapy Products Market
Table 35. Key Manufacturers Autologous Cell Therapy Products Product Type
Table 36. Mergers & Acquisitions, Expansion Plans
Table 37. Global Autologous Cell Therapy Products Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Global Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 39. Global Autologous Cell Therapy Products Sales Market Share in Volume by Region (2018-2024)
Table 40. Global Autologous Cell Therapy Products Sales by Region (2018-2024) & (US$ Million)
Table 41. Global Autologous Cell Therapy Products Sales Market Share in Value by Region (2018-2024)
Table 42. Global Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 43. Global Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 44. Global Autologous Cell Therapy Products Sales Market Share in Volume by Region (2024-2029)
Table 45. Global Autologous Cell Therapy Products Sales by Region (2024-2029) & (US$ Million)
Table 46. Global Autologous Cell Therapy Products Sales Market Share in Value by Region (2024-2029)
Table 47. Global Autologous Cell Therapy Products Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 48. Global Autologous Cell Therapy Products Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 49. Global Autologous Cell Therapy Products Sales by Application (2018-2024) & (K Units)
Table 50. Global Autologous Cell Therapy Products Sales Market Share in Volume by Application (2018-2024)
Table 51. Global Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 52. Global Autologous Cell Therapy Products Sales Market Share in Value by Application (2018-2024)
Table 53. Global Autologous Cell Therapy Products Price by Application (2018-2024) & (US$/Unit)
Table 54. Global Autologous Cell Therapy Products Sales by Application (2024-2029) & (K Units)
Table 55. Global Autologous Cell Therapy Products Sales Market Share in Volume by Application (2024-2029)
Table 56. Global Autologous Cell Therapy Products Sales by Application (2024-2029) & (US$ Million)
Table 57. Global Autologous Cell Therapy Products Sales Market Share in Value by Application (2024-2029)
Table 58. Global Autologous Cell Therapy Products Price by Application (2024-2029) & (US$/Unit)
Table 59. North America Autologous Cell Therapy Products Sales by Application (2018-2024) (K Units)
Table 60. North America Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 61. Europe Autologous Cell Therapy Products Sales by Application (2018-2024) (K Units)
Table 62. Europe Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 63. Asia-Pacific Autologous Cell Therapy Products Sales by Application (2018-2024) (K Units)
Table 64. Asia-Pacific Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 65. Latin America Autologous Cell Therapy Products Sales by Application (2018-2024) (K Units)
Table 66. Latin America Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 67. Middle East and Africa Autologous Cell Therapy Products Sales by Application (2018-2024) (K Units)
Table 68. Middle East and Africa Autologous Cell Therapy Products Sales by Application (2018-2024) & (US$ Million)
Table 69. North America Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 70. North America Autologous Cell Therapy Products Sales Market Share in Volume by Country (2018-2024)
Table 71. North America Autologous Cell Therapy Products Sales by Country (2018-2024) & (US$ Million)
Table 72. North America Autologous Cell Therapy Products Sales Market Share in Value by Country (2018-2024)
Table 73. North America Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 74. North America Autologous Cell Therapy Products Sales Market Share in Volume by Country (2024-2029)
Table 75. North America Autologous Cell Therapy Products Sales by Country (2024-2029) & (US$ Million)
Table 76. North America Autologous Cell Therapy Products Sales Market Share in Value by Country (2024-2029)
Table 77. Europe Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 78. Europe Autologous Cell Therapy Products Sales Market Share in Volume by Country (2018-2024)
Table 79. Europe Autologous Cell Therapy Products Sales by Country (2018-2024) & (US$ Million)
Table 80. Europe Autologous Cell Therapy Products Sales Market Share in Value by Country (2018-2024)
Table 81. Europe Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 82. Europe Autologous Cell Therapy Products Sales Market Share in Volume by Country (2024-2029)
Table 83. Europe Autologous Cell Therapy Products Sales by Country (2024-2029) & (US$ Million)
Table 84. Europe Autologous Cell Therapy Products Sales Market Share in Value by Country (2024-2029)
Table 85. Asia-Pacific Autologous Cell Therapy Products Sales by Region (2018-2024) & (K Units)
Table 86. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Volume by Region (2018-2024)
Table 87. Asia-Pacific Autologous Cell Therapy Products Sales by Region (2018-2024) & (US$ Million)
Table 88. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Value by Region (2018-2024)
Table 89. Asia-Pacific Autologous Cell Therapy Products Sales by Region (2024-2029) & (K Units)
Table 90. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Volume by Region (2024-2029)
Table 91. Asia-Pacific Autologous Cell Therapy Products Sales by Region (2024-2029) & (US$ Million)
Table 92. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Value by Region (2024-2029)
Table 93. Latin America Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 94. Latin America Autologous Cell Therapy Products Sales Market Share in Volume by Country (2018-2024)
Table 95. Latin America Autologous Cell Therapy Products Sales by Country (2018-2024) & (US$ Million)
Table 96. Latin America Autologous Cell Therapy Products Sales Market Share in Value by Country (2018-2024)
Table 97. Latin America Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 98. Latin America Autologous Cell Therapy Products Sales Market Share in Volume by Country (2024-2029)
Table 99. Latin America Autologous Cell Therapy Products Sales by Country (2024-2029) & (US$ Million)
Table 100. Latin America Autologous Cell Therapy Products Sales Market Share in Value by Country (2024-2029)
Table 101. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2018-2024) & (K Units)
Table 102. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Volume by Country (2018-2024)
Table 103. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2018-2024) & (US$ Million)
Table 104. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Value by Country (2018-2024)
Table 105. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2024-2029) & (K Units)
Table 106. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Volume by Country (2024-2029)
Table 107. Middle East and Africa Autologous Cell Therapy Products Sales by Country (2024-2029) & (US$ Million)
Table 108. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Value by Country (2024-2029)
Table 109. Novartis Company Information
Table 110. Novartis Introduction and Business Overview
Table 111. Novartis Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Autologous Cell Therapy Products Product
Table 113. Novartis Recent Development
Table 114. Gilead Sciences Company Information
Table 115. Gilead Sciences Introduction and Business Overview
Table 116. Gilead Sciences Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Gilead Sciences Autologous Cell Therapy Products Product
Table 118. Gilead Sciences Recent Development
Table 119. Bristol-Myers Squibb Company Information
Table 120. Bristol-Myers Squibb Introduction and Business Overview
Table 121. Bristol-Myers Squibb Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Bristol-Myers Squibb Autologous Cell Therapy Products Product
Table 123. Bristol-Myers Squibb Recent Development
Table 124. Johnson & Johnson Company Information
Table 125. Johnson & Johnson Introduction and Business Overview
Table 126. Johnson & Johnson Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Johnson & Johnson Autologous Cell Therapy Products Product
Table 128. Johnson & Johnson Recent Development
Table 129. Autolus Therapeutics Company Information
Table 130. Autolus Therapeutics Introduction and Business Overview
Table 131. Autolus Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Autolus Therapeutics Autologous Cell Therapy Products Product
Table 133. Autolus Therapeutics Recent Development
Table 134. FOSUNKite Company Information
Table 135. FOSUNKite Introduction and Business Overview
Table 136. FOSUNKite Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. FOSUNKite Autologous Cell Therapy Products Product
Table 138. FOSUNKite Recent Development
Table 139. JW Therapeutics Company Information
Table 140. JW Therapeutics Introduction and Business Overview
Table 141. JW Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. JW Therapeutics Autologous Cell Therapy Products Product
Table 143. JW Therapeutics Recent Development
Table 144. CARsgen Therapeutics Company Information
Table 145. CARsgen Therapeutics Introduction and Business Overview
Table 146. CARsgen Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. CARsgen Therapeutics Autologous Cell Therapy Products Product
Table 148. CARsgen Therapeutics Recent Development
Table 149. Sorrento Therapeutics Company Information
Table 150. Sorrento Therapeutics Introduction and Business Overview
Table 151. Sorrento Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 152. Sorrento Therapeutics Autologous Cell Therapy Products Product
Table 153. Sorrento Therapeutics Recent Development
Table 154. Mustang Bio Company Information
Table 155. Mustang Bio Introduction and Business Overview
Table 156. Mustang Bio Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 157. Mustang Bio Autologous Cell Therapy Products Product
Table 158. Mustang Bio Recent Development
Table 159. Cellectis Company Information
Table 160. Cellectis Introduction and Business Overview
Table 161. Cellectis Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 162. Cellectis Autologous Cell Therapy Products Product
Table 163. Cellectis Recent Development
Table 164. Allogene Therapeutics Company Information
Table 165. Allogene Therapeutics Introduction and Business Overview
Table 166. Allogene Therapeutics Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 167. Allogene Therapeutics Autologous Cell Therapy Products Product
Table 168. Allogene Therapeutics Recent Development
Table 169. Celyad Oncology Company Information
Table 170. Celyad Oncology Introduction and Business Overview
Table 171. Celyad Oncology Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 172. Celyad Oncology Autologous Cell Therapy Products Product
Table 173. Celyad Oncology Recent Development
Table 174. Bluebird Bio Company Information
Table 175. Bluebird Bio Introduction and Business Overview
Table 176. Bluebird Bio Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 177. Bluebird Bio Autologous Cell Therapy Products Product
Table 178. Bluebird Bio Recent Development
Table 179. Lonza Company Information
Table 180. Lonza Introduction and Business Overview
Table 181. Lonza Autologous Cell Therapy Products Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 182. Lonza Autologous Cell Therapy Products Product
Table 183. Lonza Recent Development
Table 184. Key Raw Materials Lists
Table 185. Raw Materials Key Suppliers Lists
Table 186. Autologous Cell Therapy Products Market Trends
Table 187. Autologous Cell Therapy Products Market Drivers
Table 188. Autologous Cell Therapy Products Market Challenges
Table 189. Autologous Cell Therapy Products Market Restraints
Table 190. Autologous Cell Therapy Products Distributors List
Table 191. Autologous Cell Therapy Products Downstream Customers
Table 192. Research Programs/Design for This Report
Table 193. Key Data Information from Secondary Sources
Table 194. Key Data Information from Primary Sources
List of Figures
Figure 1. Autologous Cell Therapy Products Product Picture
Figure 2. Global Autologous Cell Therapy Products Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Autologous Cell Therapy Products Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Autologous Cell Therapy Products Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Autologous Stem Cell Transplants
Figure 6. Global Autologous Stem Cell Transplants Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Autologous T Cell Therapies
Figure 8. Global Autologous T Cell Therapies Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Platelet-Rich Plasma (PRP) Therapy
Figure 10. Global Platelet-Rich Plasma (PRP) Therapy Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Product Picture of Others
Figure 12. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 13. Global Autologous Cell Therapy Products Sales by Type (2018-2029) & (US$ Million)
Figure 14. Global Autologous Cell Therapy Products Sales Market Share by Type in 2022 & 2029
Figure 15. North America Autologous Cell Therapy Products Sales Market Share in Volume by Type in 2022
Figure 16. North America Autologous Cell Therapy Products Sales Market Share in Value by Type in 2022
Figure 17. Europe Autologous Cell Therapy Products Sales Market Share in Volume by Type in 2022
Figure 18. Europe Autologous Cell Therapy Products Sales Market Share in Value by Type in 2022
Figure 19. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Volume by Type in 2022
Figure 20. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Value by Type in 2022
Figure 21. Latin America Autologous Cell Therapy Products Sales Market Share in Volume by Type in 2022
Figure 22. Latin America Autologous Cell Therapy Products Sales Market Share in Value by Type in 2022
Figure 23. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Volume by Type in 2022
Figure 24. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Value by Type in 2022
Figure 25. The 5 and 10 Largest Manufacturers in the World: Market Share by Autologous Cell Therapy Products Sales in 2022
Figure 26. The 5 and 10 Largest Manufacturers in the World: Market Share by Autologous Cell Therapy Products Revenue in 2022
Figure 27. Autologous Cell Therapy Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 28. Product Picture of Cancer
Figure 29. Global Cancer Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Hemophilia
Figure 31. Global Hemophilia Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Others
Figure 33. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Global Autologous Cell Therapy Products Sales by Application (2018-2029) & (US$ Million)
Figure 35. Global Autologous Cell Therapy Products Sales Market Share by Application in 2022 & 2029
Figure 36. North America Autologous Cell Therapy Products Sales Market Share in Volume by Application in 2022
Figure 37. North America Autologous Cell Therapy Products Sales Market Share in Value by Application in 2022
Figure 38. Europe Autologous Cell Therapy Products Sales Market Share in Volume by Application in 2022
Figure 39. Europe Autologous Cell Therapy Products Sales Market Share in Value by Application in 2022
Figure 40. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Volume by Application in 2022
Figure 41. Asia-Pacific Autologous Cell Therapy Products Sales Market Share in Value by Application in 2022
Figure 42. Latin America Autologous Cell Therapy Products Sales Market Share in Volume by Application in 2022
Figure 43. Latin America Autologous Cell Therapy Products Sales Market Share in Value by Application in 2022
Figure 44. Middle East and Africa Autologous Cell Therapy Products Sales Market Share in Value by Application in 2022
Figure 45. Key Raw Materials Price
Figure 46. Autologous Cell Therapy Products Manufacturing Cost Structure
Figure 47. Autologous Cell Therapy Products Industrial Chain Analysis
Figure 48. Channels of Distribution
Figure 49. Distributors Profiles
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries